microRNA-145在子宫内膜异位症中的研究进展

高爽; 徐鹏; 王蓓蒂; 李栗扬; 郭钰; 匡野

doi:10.16766/j.cnki.issn.1674-4152.002201

microRNA-145在子宫内膜异位症中的研究进展

doi: 10.16766/j.cnki.issn.1674-4152.002201

高爽¹,
徐鹏²,
王蓓蒂¹,
李栗扬¹,
郭钰¹,
匡野^1, ,

1.
哈尔滨医科大学附属第二医院妇产科，黑龙江哈尔滨 150086
2.
哈尔滨医科大学附属第二医院院长办公室，黑龙江哈尔滨 150086

基金项目:

吴阶平医学基金会临床科研课题项目 320675018061

详细信息

通讯作者:
匡野，E-mail：kuangye-blue@163.com

中图分类号: R711.71
计量
- 文章访问数: 121
- HTML全文浏览量: 209
- PDF下载量: 3
- 被引次数: 0
出版历程
- 收稿日期: 2020-08-10
- 网络出版日期: 2022-02-15

Research progress of microRNA-145 in endometriosis

1.
Department of Obstetrics and Gynaecology, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China

摘要

摘要: 子宫内膜异位症(EMs)是一种常见的雌激素依赖性疾病，病因尚不明确。表观遗传异常可能是EMs的潜在致病机制，它改变了激素和环境因素对基因表达的反应，其中小分子RNA(miRNA)的差异性表达在EMs的发生、发展过程中发挥一定作用。miRNA是一种非编码调节性单链RNA，通过与信使RNA(mRNA)的3'非编码区(3' UTR)结合在转录或转录后的水平上调节基因表达。已有大量的研究揭示了miRNA作为EMs潜在的强有力的生物标记，这些失调的miRNA中，有些直接参与了疾病的发生，而另一些则与疾病的存在相关，但它们的生物学作用尚不清楚。在这些miRNA中，miR-145在EMs中存在明显的差异性表达。miR-145通过介导细胞黏附分子和细胞骨架元素，如纤溶酶原激活物抑制物-1(PAI-1)、八聚体结合转录因子4(OCT4)以及肌成束蛋白-1(FSCN1)等因子影响内异症病灶的生成。miR-145还受其上游RNA分子的调控，如长链非编码RNA(lncRNA)前列腺癌相关转录物1(PCAT1)可通过miR-145信号通路靶向调控特定基因的表达，从而对EMs的患病风险产生影响。此外，miR-145表达水平的变化可能与EMs中的不孕症有关。本文旨在阐述miR-145在内异症中的作用机制，主要包括细胞的血管形成、腹膜黏附、侵袭、迁移、增殖、自噬、不孕症等内容，以期为临床治疗EMs提供进一步的理论支持。
- microRNA-145 /
- 子宫内膜异位症 /
- 发病机制
Abstract: Endometriosis (EMs) is a common oestrogen-dependent disease, the cause of which is not clear. Epigenetic abnormality may be a potential pathogenic mechanism of EM, which changes the response of hormones and environmental factors to gene expression. Amongst them, small microRNAs (miRNAs) are differentially expressed in EM and play a certain role in the occurrence and development of the disease. miRNAs are non-coding regulatory single-stranded RNAs that regulate gene expression at the transcription or post-transcription level by binding to the 3′ untranslated region of mRNA. Several studies have revealed that miRNAs are potentially powerful biomarkers of EM. Some of these dysregulated miRNAs are directly involved in the occurrence of diseases, whilst others are related to the existence of diseases. However, their biological role is unclear. Amongst these miRNAs, miR-145 has obvious differential expression in EM. miR-145 mediates cell adhesion molecules and cytoskeletal elements, such as plasminogen activator inhibitor-1, octamer-binding transcription factor-4 and FSCN1. miR-145 is also regulated by its upstream RNA molecules. For example, long non-coding RNA prostate cancer-associated transcript 1 can have an impact on the risk of EM through the miR-145 signalling pathway that targets and regulates the expression of specific genes. In addition, the changes of miR-145 expression levels may be related to infertility in EM. This study aims to describe the mechanism of action of miR-145 in EM, including cell angiogenesis, peritoneal adhesion, invasion, migration, proliferation, autophagy and infertility, in order to provide further theoretical support for the clinical treatment of EM.
- MicroRNA-145 /
- Endometriosis /
- Pathogenesis

HTML全文

参考文献(48)

[1]	MASHAYEKHI P, NORUZINIA M, ZEINALI S, et al. Endometriotic mesenchymal stem cells epigenetic pathogenesis: Deregulation of miR-200b, miR-145, and let7b in a functional imbalanced epigenetic disease[J]. Cell J, 2019, 21(2): 179-185. http://www.ncbi.nlm.nih.gov/pubmed/30825291
[2]	WANG Y, NICHOLES K, SHIH I M. The origin and pathogenesis of endometriosis[J]. Annu Rev Pathol, 2020, 15: 71-95. doi: 10.1146/annurev-pathmechdis-012419-032654
[3]	TAGHAVIPOUR M, SADOUGHI F, MIRZAEI H, et al. Apoptotic functions of microRNAs in pathogenesis, diagnosis, and treatment of endometriosis[J]. Cell Biosci, 2020. DOI: 10.1186/s13578-020-0381-0.
[4]	NOTHNICK W, ALALI Z. Recent advances in the understanding of endometriosis: The role of inflammatory mediators in disease pathogenesis and treatment[J]. F1000Res, 2016. DOI: 10.12688/f1000research.7504.1.
[5]	BJORKMAN S, TAYLOR H S. MicroRNAs in endometriosis: Biological function and emerging biomarker candidatesdagger?[J]. Biol Reprod, 2019, 100(5): 1135-1146. http://oldmed.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_edcaae2e685df431be068fe54272e209
[6]	PEREZ-CREMADES D, MOMPEON A, VIDAL-GOMEZ X, et al. Role of miRNA in the regulatory mechanisms of estrogens in cardiovascular ageing[J]. Oxid Med Cell Longev, 2018(2): 1-16. http://downloads.hindawi.com/journals/omcl/2018/6082387.pdf
[7]	CHENG F, LU L Y, WANG H X, et al. Expression and significance of miR-126 and miR-145 in infertility due to endometriosis[J]. J Coll Physicians Surg Pak, 2019, 29(6): 585-587. doi: 10.29271/jcpsp.2019.06.585
[8]	AGRAWAL S, TAPMRIER T, RAHMIOGLU N, et al. The miRNA mirage: How close are we to finding a non-invasive diagnostic biomarker in endometriosis?A systematic review[J]. Int J Mol Sci, 2018, 19(2): 599. doi: 10.3390/ijms19020599
[9]	NOTHNICK W B. MicroRNAs and endometriosis: Distinguishing drivers from passengers in disease pathogenesis[J]. Semin Reprod Med, 2017, 35(2): 173-180. doi: 10.1055/s-0037-1599089
[10]	BAYRAKTAR R, VAN-ROOSBROECK K, CALIN G A. Cell-to-cell communication: MicroRNAs as hormones[J]. Mol Oncol, 2017, 11(12): 1673-1686. doi: 10.1002/1878-0261.12144
[11]	王润秋, 彭程, 方前进, 等. 腹腔镜子宫内膜异位症手术效果分析[J]. 中华全科医学, 2019, 17(8): 1347-1349. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201908028.htm
[12]	RAJASEKARAN S, PATTARAYAN D, RAJAGURU P, et al. MicroRNA regulation of acute lung injury and acute respiratory distress syndrome[J]. J Cell Physiol, 2016, 231(10): 2097-2106. doi: 10.1002/jcp.25316
[13]	PERAKIS S O, THOMAS J E, PICHLER M. Non-coding RNAs enabling prognostic stratification and prediction of therapeutic response in colorectal cancer patients[J]. Adv Exp Med Biol, 2016, 937: 183-204. doi: 10.1007/978-3-319-42059-2
[14]	MARI-ALEXANDRE J, BARCELO-MOLINA M, BELMONTE-LOPEZ E, et al. Micro-RNA profile and proteins in peritoneal fluid from women with endometriosis: Their relationship with sterility[J]. Fertil Steril, 2018, 109(4): 675-684. doi: 10.1016/j.fertnstert.2017.11.036
[15]	SALIMINEJAD K, KHORRAM K H, SOLEYMANI F S, et al. An overview of microRNAs: Biology, functions, therapeutics, and analysis methods[J]. J Cell Physiol, 2019, 234(5): 5451-5465. doi: 10.1002/jcp.27486
[16]	HAIKALIS M E, WESSELS J M, LEYLAND N A, et al. MicroRNA expression pattern differs depending on endometriosis lesion type[J]. Biol Reprod, 2018, 98(5): 623-633. doi: 10.1093/biolre/ioy019
[17]	YANG R Q, TENG H, XU X H, et al. Microarray analysis of microRNA deregulation and angiogenesis-related proteins in endometriosis[J]. Genet Mol Res, 2016. DOI: 10.4238/gmr.15027826.
[18]	HE M, WU N, LENOG M C, et al. miR-145 improves metabolic inflammatory disease through multiple pathways[J]. J Mol Cell Biol, 2020, 12(2): 152-162. doi: 10.1093/jmcb/mjz015
[19]	HUANG W, HUANG C, DING H, et al. Involvement of miR-145 in the development of aortic dissection via inducing proliferation, migration, and apoptosis of vascular smooth muscle cells[J]. J Clin Lab Anal, 2020. DOI: 10.1002/jcla.23028.
[20]	ADAMMEK M, GREVE B, KASSENS N, et al. MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors[J]. Fertil Steril, 2013, 99(5): 1346-1355. doi: 10.1016/j.fertnstert.2012.11.055
[21]	COSAR E, MAMILLAPALLI R, ERSOY G S, et al. Serum microRNAs as diagnostic markers of endometriosis: A comprehensive array-based analysis[J]. Fertil Steril, 2016, 106(2): 402-409. doi: 10.1016/j.fertnstert.2016.04.013
[22]	ALOTAIBI F T, PENG B, KLAUSEN C, et al. Plasminogen activator inhibitor-1 (PAI-1) expression in endometriosis[J]. PLoS One, 2019, 14(7): e0219064. doi: 10.1371/journal.pone.0219064
[23]	BUIGUES A, FERRERO H, MARTINEZ J, et al. Evaluation of PAI-1 in endometriosis using a homologous immunocompetent mouse model[J]. Biol Reprod, 2018, 99(2): 326-335. doi: 10.1093/biolre/ioy057
[24]	ZHANG Y, PAN Y, XIE C, et al. miR-34a exerts as a key regulator in the dedifferentiation of osteosarcoma via PAI-1-Sox2 axis[J]. Cell Death Dis, 2018, 9(7): 777. doi: 10.1038/s41419-018-0778-4
[25]	LIU X M, ZHAO H S, LI W S, et al. Up-regulation of miR-145 may contribute to repeated implantation failure after IVF-embryo transfer by targeting PAI-1[J]. Reprod Biomed Online, 2020, 40(5): 627-636. doi: 10.1016/j.rbmo.2020.01.018
[26]	CAROLINA ARRUDA D F, DALILA L Z, WILSON ARAUJO S J, et al. PAI-1 inhibition by simvastatin as a positive adjuvant in cell therapy[J]. Mol Biol Rep, 2019, 46(1): 1511-1517. doi: 10.1007/s11033-018-4562-4
[27]	CHEN Y, YANG C W, LI Y J, et al. MiR145-5p inhibits proliferation of PMVECs via PAI-1 in experimental hepatopulmonary syndrome rat pulmonary microvascular hyperplasia[J]. Biol Open, 2019, 8(11): bio044800.
[28]	刘敏娟, 马颖. miRNA在子宫内膜异位症发病中作用的研究进展[J]. 山东医药, 2018, 58(32): 105-107. doi: 10.3969/j.issn.1002-266X.2018.32.030
[29]	JEVRIC M, MATIC I Z, KRIVOKUCA A, et al. Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy[J]. BMC Cancer, 2019, 19(1): 71. doi: 10.1186/s12885-018-5255-z
[30]	WANG X Y, LIU C, WANG J Q, et al. Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-β1/Smad signaling pathway[J]. Oncol Rep, 2017, 37(2): 747-753. doi: 10.3892/or.2016.5292
[31]	CHEN X L, JIANG Y, PAN D L. miR-30c may serve a role in endometriosis by targeting plasminogen activator inhibitor-1[J]. Exp Ther Med, 2017, 14(5): 4846-4852. doi: 10.3892/etm.2017.5145/download
[32]	LUO X M, CHENG W, WANG S Z, et al. Autophagy suppresses invasiveness of endometrial cells through reduction of Fascin-1[J]. Biomed Res Int, 2018. DOI: 10.1155/2018/8615435.
[33]	PROESTLING K, BIRNER P, BALENDRAN S, et al. Enhanced expression of the stemness-related factors OCT4, SOX15 and TWIST1 in ectopic endometrium of endometriosis patients[J]. Reprod Biol Endocrinol, 2016, 14(1): 81. doi: 10.1186/s12958-016-0215-4
[34]	CHENG Y, LI L, WANG D, et al. Characteristics of human endometrium-derived mesenchymal stem cells and their tropism to endometriosis[J]. Stem Cells Int, 2017. DOI: 10.1155/2018/8615435.
[35]	OTHMAN E R, MELIGY F Y, SAYED A A, et al. Stem cell markers describe a transition from somatic to pluripotent cell states in a rat model of endometriosis[J]. Fertil Steril, 2016, 106(3): e84. http://www.onacademic.com/detail/journal_1000039645057810_af87.html
[36]	MASHAYEKHI P, NORUZINIA M, KHODAVERDI S. Deregulation of stemness-related genes in endometriotic mesenchymal stem cells: Further evidence for self-renewal/differentiation imbalance[J]. Iran Biomed J, 2020, 24(5): 333-339. http://www.researchgate.net/publication/341550059_Deregulation_of_Stemness-Related_Genes_in_Endometriotic_Mesenchymal_Stem_Cells_Further_Evidence_for_Self-RenewalDifferentiation_Imbalance
[37]	SALAMA E, ELDEENG N, ABDEL R M, et al. Differentially expressed genes: OCT-4, SOX2, STAT3, CDH1 and CDH2, in cultured mesenchymal stem cells challenged with serum of women with endometriosis[J]. J Genet Eng Biotechnol, 2018, 16(1): 63-69. doi: 10.1016/j.jgeb.2017.10.006
[38]	SHARIATI F, FAVAEDI R, RAMAZANALI F, et al. Increased expression of stemness genes REX-1, OCT-4, NANOG, and SOX-2 in women with ovarian endometriosis versus normal endometrium: A case-control study[J]. Int J Reprod Biomed(Yazd), 2018, 16(12): 783-790. http://www.ncbi.nlm.nih.gov/pubmed/31417979
[39]	RICHARDS E G, ZHENG Y, SHENOY C C, et al. KLF11 is an epigenetic mediator of DRD2/dopaminergic signaling in endometriosis[J]. Reprod Sci, 2017, 24(8): 1129-1138. doi: 10.1177/1933719117698582
[40]	RAMIREZ W L, BRUGGEMANN K, HUBERT M, et al. Vgamma-Secretase inhibition affects viability, apoptosis, and the stem cell phenotype of endometriotic cells[J]. Acta Obstet Gynecol Scand, 2019, 98(12): 1565-1574. doi: 10.1111/aogs.13707
[41]	WANG W R, CHEN L F, SHANG C X, et al. miR-145 inhibits the proliferation and migration of vascular smooth muscle cells by regulating autophagy[J]. J Cell Mol Med, 2020, 24(12): 6658-6669. doi: 10.1111/jcmm.15316
[42]	XU W B, CHANG J K, DU X Y, et al. Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer[J]. Biomed Pharmacother, 2017, 95: 1112-1118. doi: 10.1016/j.biopha.2017.09.019
[43]	LIN Y D, GE Y Q, WANG Y Y, et al. The association of rs710886 in lncRNA PCAT1 with bladder cancer risk in a Chinese population[J]. Gene, 2017, 627: 226-232. doi: 10.1016/j.gene.2017.06.021
[44]	WANG L M, XING Q, FENG T F, et al. SNP rs710886 A>G in long noncoding RNA PCAT1 is associated with the risk of endometriosis by modulating expression of multiple stemness-related genes via microRNA-145 signaling pathway[J]. J Cell Biochem, 2020, 121(2): 1703-1715. doi: 10.1002/jcb.29406
[45]	WEN J F, XU J, SUN Q F, et al. Upregulation of long non coding RNA PCAT-1 contributes to cell proliferation, migration and apoptosis in hepatocellular carcinoma[J]. Mol Med Rep, 2016, 13(5): 4481-4486. doi: 10.3892/mmr.2016.5075
[46]	MISIURA M, ZINCZUK J, ZAREBA K, et al. Actin-bundling proteins (Actinin-4 and Fascin-1) are involved in the development of pancreatic intraepithelial neoplasia (PanIN)[J]. Am J Med Sci, 2020, 359(3): 147-155. doi: 10.1016/j.amjms.2019.11.013
[47]	YONG P J, MATWANI S, BRACE C, et al. Endometriosis and ectopic pregnancy: A meta-analysis[J]. J Minim Invasive Gynecol, 2020, 27(2): 352-361. doi: 10.1016/j.jmig.2019.09.778
[48]	KHAN Z. Fertility-related considerations in endometriosis[J]. Abdom Radiol(NY), 2020, 45(3): 1-8.